** Wells Fargo initiates coverage on dental products company
Envista Holdings NVST.N with an "equal weight" rating; PT at
$20
** Brokerage expects inflationary environment to impact
dental implants demand, given the significant out-of-pocket cost
for patients
** NVST has underperformed the dental market; limited
opportunity for the stock to outperform over the next 12 months
- Wells Fargo
** Three of 13 brokerages rate the stock "buy" or higher,
nine "hold" and one "sell"; their median PT is $18.50 - LSEG
data
** Including session's moves, stock fell ~24% YTD
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))